Chachoua A - Search Results

1

Barriers and engagement in breast cancer survivorship wellness activities.

Szuhany KL, Malgaroli M, Riley G, Miron CD, Suzuki R, Park JH, Rosenthal J, Chachoua A, Meyers M, Simon NM. Szuhany KL, et al. Among authors: chachoua a. Breast Cancer Res Treat. 2021 Jul;188(1):317-325. doi: 10.1007/s10549-021-06279-4. Epub 2021 Jun 7. Breast Cancer Res Treat. 2021. PMID: 34095986 Free PMC article.

2

Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis.

Malgaroli M, Szuhany KL, Riley G, Miron CD, Park JH, Rosenthal J, Chachoua A, Meyers M, Simon NM. Malgaroli M, et al. Among authors: chachoua a. J Cancer Surviv. 2023 Oct;17(5):1510-1521. doi: 10.1007/s11764-022-01195-y. Epub 2022 Feb 28. J Cancer Surviv. 2023. PMID: 35224684 Free PMC article.

3

Phase I study of the combination of alpha-2 interferon and cisplatinum.

Walsh C, Speyer JL, Wernz J, Hochster H, Grossberg H, Chachoua A, Molinaro P, Meyers M, Blum RH. Walsh C, et al. Among authors: chachoua a. J Biol Response Mod. 1989 Feb;8(1):11-5. J Biol Response Mod. 1989. PMID: 2921608

4

[No title available]

[No authors listed] [No authors listed] PMID: 34701209

5

An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

Golden EB, Demaria S, Schiff PB, Chachoua A, Formenti SC. Golden EB, et al. Among authors: chachoua a. Cancer Immunol Res. 2013 Dec;1(6):365-72. doi: 10.1158/2326-6066.CIR-13-0115. Cancer Immunol Res. 2013. PMID: 24563870 Free PMC article.

6

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

Wasserheit C, Frazein A, Oratz R, Sorich J, Downey A, Hochster H, Chachoua A, Wernz J, Zeleniuch-Jacquotte A, Blum R, Speyer J. Wasserheit C, et al. Among authors: chachoua a. J Clin Oncol. 1996 Jul;14(7):1993-9. doi: 10.1200/JCO.1996.14.7.1993. J Clin Oncol. 1996. PMID: 8683229 Clinical Trial.

7

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Blum RH, Zeleniuch-Jacquotte A. Hochster H, et al. Among authors: chachoua a. Clin Cancer Res. 1997 Aug;3(8):1245-52. Clin Cancer Res. 1997. PMID: 9815806 Clinical Trial.

8

Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).

Chachoua A, Green M, Wernz J, Muggia F. Chachoua A, et al. Invest New Drugs. 1989 Nov;7(4):327-31. doi: 10.1007/BF00173762. Invest New Drugs. 1989. PMID: 2513285

9

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. Hochster H, et al. Among authors: chachoua a. J Clin Oncol. 1994 Mar;12(3):553-9. doi: 10.1200/JCO.1994.12.3.553. J Clin Oncol. 1994. PMID: 8120553 Clinical Trial.

10

Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies.

Rosenthal MA, Dennis D, Liebes L, Furmanski P, Caron D, Garrison L, Wiprovnick J, Peace D, Oratz R, Speyer J, Chachoua A. Rosenthal MA, et al. Among authors: chachoua a. J Immunother. 1998 Sep;21(5):371-8. doi: 10.1097/00002371-199809000-00005. J Immunother. 1998. PMID: 9789199 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters